Universal face masking reduces endophthalmitis incidence during anti-VEGF injections
Dr Sunir J. Garg speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.
HAWK study: Higher order OCT analysis for inflammatory signal biomarkers
Dr Justis P. Ehlers discusses the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study.
Biophytis expands patient recruitment for part II of COVA Study in France, Belgium
Biophytis will begin recruiting patients in France and Belgium for the second part of the COVA Study analyzing its leading drug candidate as a potential treatment for acute respiratory failure linked to COVID-19.
Analysis of an investigational ophthalmic solution for treating presbyopia-related symptoms
Michael R. Robinson, MD, Allergan, discusses the results from a study analyzing an investigational ophthalmic solution for treatment of symptoms associated with presbyopia presented during the virtual AAO 2020 meeting.
Evaluating long-term safety for micro-bypass implant + phaco in PXG
Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.
Controlling postop pain, inflammation in cataract patients: drug delivery vs drops
John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.
COVID-19: How Orbis International is managing operations
COVID-19: Putting safety measures into practice
COVID-19: Impact of pandemic on Switzerland's ophthalmic space
COVID-19: Life in the time of coronavirus
2 Commerce Drive Cranbury, NJ 08512